The new clinical trial rules in India for the year 2019 have reduced the time for approving applications. The time taken for approval of drugs in India was the main reason why foreign companies restricted themselves from conducting trials in India. Realizing this and working on it, the ISCR has…
India is a country with a population of nearly 1.3 billion, comprising of a varied genetic background of all kinds of castes and creeds. With such a large population, India carries a huge burden of all kinds of diseases. Thus, it offers a large treatment-nave patient pool for the development…
With the amount of stress every individual is facing today, may it be in terms of money, family, career, exams, relationships, or any other facet, depression is becoming a common condition, more than ever before! Scientists are thus finding a way to reduce the symptoms of depression among people so…
Almost 70,000 women die every year in India because of the dangerous disease which is known as cervical cancer! To reduce or eliminate this number, a lifesaving vaccine known as “human papillomavirus” (HPV) has been found, but hasn’t yet been approved to be used publicly. Cervical cancer is one of…
Verily, the Life Sciences unit of Google parent Alphabet, has developed, with Google, a machine learning algorithm that can assess images for diabetic eye diseases. This automated screening tool checks for two leading causes of blindness seen in India – diabetic retinopathy and diabetic macular edema. The goal of detecting…
The 12th annual ISCR Conference was recently held in Delhi, where the theme was “Advancing the frontiers of health”. More than 500 clinical research professionals attended the conference to discuss how clinical trial reforms would build the future of Indian research and opportunities in India. The President of ISCR, Dr….
The Racefor7 is an event that is to take place on 24th February 2019, wherein runners across the U.S. and India will join together to participate, in the event of raising awareness and empowering patients with rare diseases in the quest for effective treatment options. The aim of this collaboration…
Scientists in London are testing the effectiveness of a drug that is currently used to treat ailments of the liver, to slow down the progression of Parkinson’s disease. After testing around 2000 drugs, researchers identified ursodeoxycholic acid (UDCA) as the most promising drug to treat mitochondrial function in Parkinson’s disease….
Just providing improved access to healthcare is not enough to bring about better outcomes; it is essential to invest in primary care with the objective of improving both access and quality of care. The Union Government has strengthened efforts to focus on health programs that can provide good health care…
